Fig. 1. Overall survival of patients TIMELESS rs2291739 variants.
a Oxaliplatin cohort (FOLFOX plus bevacizumab arm). b Irinotecan cohort (FOLFIRI plus bevacizumab arm). Abbreviations: OS, overall survival.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.